Singer P A, Daar A S
Joint Centre for Bioethics and Departments of Medicine, Public Health Sciences, and Surgery, University of Toronto, Toronto, Canada.
Science. 2001 Oct 5;294(5540):87-9. doi: 10.1126/science.1062633.
With decisive and timely action, genome-related biotechnology can be harnessed to improve global health equity. In June 2002 in Kananaskis, Canada, leaders of the G8 industrial nations will develop an action plan to support implementation of the New African Initiative. By extending their discussion of health issues raised in the New African Initiative to include genomics, G8 leaders could signal their intention to increase global health equity by preventing a health genomics divide from developing. There are already some early and growing examples of genome-related biotechnology being applied successfully to health problems in developing countries. But how can genomics be systematically harnessed to benefit health in developing countries? We propose a five-point strategy, including research, capacity strengthening, consensus building, public engagement, and an investment fund.
通过果断及时的行动，与基因组相关的生物技术能够被用于改善全球卫生公平性。2002年6月在加拿大卡纳纳斯基斯，八国集团工业国领导人将制定一项行动计划，以支持《新非洲倡议》的实施。通过将他们对《新非洲倡议》中提出的卫生问题的讨论扩展到包括基因组学，八国集团领导人可以表明他们有意通过防止卫生基因组学鸿沟的出现来增强全球卫生公平性。已经有一些早期且不断增加的例子表明，与基因组相关的生物技术已成功应用于发展中国家的卫生问题。但是，如何系统地利用基因组学使发展中国家的卫生受益呢？我们提出了一项五点战略，包括研究、能力建设、建立共识、公众参与和一个投资基金。
